EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Dynavax Technologies Corp. (DVAX) on Thursday reported third-quarter net income of $17.6 million. On a per-share basis, the Emeryville, ...
Dynavax Technologies Corporation (Nasdaq: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced its Board of Directors has authorized ...
engages in the discovery and development of innovative therapeutics derived from platform of antibody technologies. Its products includes X358, X213, X129, and gevokizumab. The company was founded by ...
President-elect Trump is projected to win the popular vote in the presidential election, a feat not achieved by a Republican candidate in 20 years. Current vote counts show Trump surpassing Vice ...